The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Nasolacrimal Duct Obstruction

Blockage of the lacrimal drainage system causing chronic tearing (epiphora) and recurrent infections (dacryocystitis), classified as congenital or acquired (primary acquired NLDO, traumatic, post-inflammatory, neoplastic), diagnosed by lacrimal probing, dye disappearance test, and dacryocystography, treated with massage in infants, probing/intubation, or dacryocystorhinostomy (DCR) in adults.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Göz Hastalıkları department. Book Appointment →

What is Nasolacrimal Duct Obstruction?

Nasolacrimal duct obstruction (NLDO) is impaired drainage of tears through the lacrimal system from the punctum, canaliculi, lacrimal sac, into the nasolacrimal duct and nasal cavity. Tears produced by lacrimal gland and accessory glands normally drain via the puncta (upper and lower), canaliculi joining at common canaliculus, into the lacrimal sac, then nasolacrimal duct opening at the inferior meatus through the valve of Hasner.

Classification: Congenital NLDO (CNLDO) affects 5-20% of newborns due to incomplete canalization at the valve of Hasner, with 90% spontaneous resolution by age 1; primary acquired NLDO (PANDO) is most common in postmenopausal women (3-7:1 female:male) due to anatomic narrowing, hormonal effects, age-related fibrosis; secondary acquired causes include trauma (midfacial fractures), infection (chronic dacryocystitis, granulomatous inflammation, sarcoidosis), inflammation (Wegener's, IgG4-related), neoplasm (lacrimal sac tumors, lymphoma, squamous cell carcinoma), iatrogenic (post-sinus surgery, radiation), systemic medications (5-FU, docetaxel, radioactive iodine).

Presentation includes epiphora (constant tearing), mucopurulent discharge especially with sac compression, recurrent conjunctivitis, and acute or chronic dacryocystitis (lacrimal sac inflammation/abscess). Diagnosis: Jones I test (fluorescein recovery from nose), Jones II (irrigation with regurgitation indicates obstruction), dye disappearance test, lacrimal probing/irrigation in office, dacryocystography (radiographic), dacryoscintigraphy (functional), and CT/MRI for tumor or trauma. Endonasal endoscopy assesses the valve of Hasner. Treatment of CNLDO: lacrimal sac massage (Crigler maneuver) and topical antibiotics for infections in first 12 months; probing under general anesthesia after 12 months (success >90% at first probing); silicone intubation for failed probing or older children; balloon catheter dilation for recurrent obstruction. Adult NLDO: external dacryocystorhinostomy (DCR) creates an anastomosis between lacrimal sac and nasal cavity (success >90%), endoscopic endonasal DCR avoids skin scar (success 85-95%), laser DCR less common, conjunctivodacryocystorhinostomy (CDCR) with Jones tube for canalicular obstruction. Acute dacryocystitis: warm compresses, oral antibiotics (amoxicillin/clavulanate, cephalexin), incision and drainage if abscess; definitive DCR after acute resolution. Probiotic intubation for partial obstruction. Tumor evaluation with biopsy if mass, blood-tinged tears, or atypical presentation.

Symptoms

Constant tearing (epiphora) - cardinal symptom
Mucopurulent discharge from punctum
Crusting on lashes, sticky eyes especially morning
Recurrent conjunctivitis
Reflux of mucopurulent material with sac pressure
Acute dacryocystitis: tender, red, swollen lacrimal sac
Lacrimal sac abscess, fistula formation (chronic)
Cellulitis spreading from sac
Blurred vision from tearing
Photophobia in infants with severe CNLDO
Bloody tears (suspicious for tumor)

Risk Factors

Newborn (CNLDO, valve of Hasner imperforation)
Postmenopausal women (PANDO most common)
Older age (anatomic narrowing)
Female sex (3-7:1 for PANDO)
Trauma: midfacial fractures, NOE complex
Chronic sinusitis, allergic rhinitis
Granulomatous disease: Wegener's, sarcoidosis, IgG4
Lacrimal sac tumors (rare, important to exclude)
Prior nasal/sinus surgery, radiation
Topical glaucoma medications
Systemic chemotherapy (5-FU, docetaxel)
Radioactive iodine for thyroid cancer

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Persistent tearing in infant beyond 12 months
  • Tearing with mucopurulent discharge
  • Recurrent conjunctivitis or dacryocystitis
  • Painful, red swelling near medial canthus (acute dacryocystitis)
  • Blood-tinged tears (urgent, exclude tumor)
  • Lacrimal sac mass, fistula
  • Tearing affecting daily activities, vision
  • Failed probing in pediatric patients
  • Adult-onset epiphora
  • Tearing with prior trauma or surgery

Treatment Methods

01
CNLDO: lacrimal sac massage (Crigler maneuver), topical antibiotics for infection
02
CNLDO probing under GA after 12 months (success >90%)
03
Silicone intubation for failed probing or older children
04
Balloon catheter dilation for recurrent CNLDO
05
External dacryocystorhinostomy (DCR) - gold standard adults
06
Endoscopic endonasal DCR (no skin scar)
07
Laser DCR (less commonly used)
08
Conjunctivodacryocystorhinostomy (CDCR) with Jones tube
09
Acute dacryocystitis: warm compresses, oral antibiotics
10
Incision and drainage if abscess
11
Definitive DCR after acute resolution
12
Probiotic intubation for partial obstruction
13
Lacrimal sac biopsy if tumor suspected
14
Treat underlying systemic disease (sarcoid, GPA, IgG4)

Which Department to Visit?

You can visit our Göz Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Göz Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.